Cardiovascular diseases Trials in Helsinki, Finland
Conditions / Cardiovascular diseases / Helsinki, Finland
Clinical trials for Cardiovascular diseases investigate a range of treatment strategies and patient populations.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT00153101 | Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. | COMPLETED | PHASE4 |
| NCT04444583 | Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS) FI | COMPLETED | — |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT06575907 | Health, Functioning, Work, and Experiences of Social and Health Services of Persons With Stroke | ACTIVE_NOT_RECRUITING | — |
| NCT04442334 | The European NAFLD Registry | RECRUITING | — |
| NCT02699736 | EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV | ENROLLING_BY_INVITATION | — |
| NCT04271280 | Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events | COMPLETED | — |
| NCT02686502 | Motivation Makes the Move! | COMPLETED | NA |